Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study
Identifieur interne : 002260 ( Main/Curation ); précédent : 002259; suivant : 002261Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study
Auteurs : Alberto J. Espay [Canada, États-Unis] ; Dorcas E. Beaton [Canada] ; Francesca Morgante [Canada, Italie] ; Carolyn A. Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 2009-05-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Amplitude, Biomechanical Phenomena, Cross-Sectional Studies, Disability Evaluation, Evaluation scale, Female, Humans, Hypokinesia (etiology), Male, Middle Aged, Nervous system diseases, Parkinson Disease (complications), Parkinson disease, Parkinson's disease, Pilot Projects, Psychomotor Performance (physiology), Reproducibility of Results, Severity of Illness Index, Speed, Task Performance and Analysis, bradykinesia, unified Parkinson's disease rating scale.
- MESH :
- complications : Parkinson Disease.
- etiology : Hypokinesia.
- physiology : Psychomotor Performance.
- Aged, Aged, 80 and over, Biomechanical Phenomena, Cross-Sectional Studies, Disability Evaluation, Female, Humans, Male, Middle Aged, Pilot Projects, Reproducibility of Results, Severity of Illness Index, Task Performance and Analysis.
Abstract
Bradykinesia, characterized by slowness and decreased amplitude of movement, is often considered the most important deficit in Parkinson's disease (PD). The current clinical rating of bradykinesia in PD, based on the motor subscale of the Unified Parkinson's disease Rating Scale (UPDRS‐III), does not individually weigh the impairments in speed and amplitude of rapid alternating movements. We sought to categorize movement in PD to determine whether speed and amplitude have different relationships to current measures of motor impairment and disability. Categories of speed and amplitude (normal, slow/low, and very‐slow/very‐low) were ascertained using an electromagnetic tracking device. Amplitude was disproportionally more affected than speed in the “off” state. UPDRS‐III and the Schwab & England disability scale were worst in patients with very impaired amplitude and best in patients with normal amplitude. A similarly graded relationship was not found for categories of speed impairment. The examiner clinical global impression of change mirrored “off” state amplitude but not speed categories. Levodopa, however, normalized speed to a greater extent than amplitude. Our observations suggest that amplitude and speed impairments may be associated with different functional aspects in PD and deserve separate clinical assessment. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22480
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001106
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001106
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000E62
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E06
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001E06
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001D66
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002571
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :002571
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002571
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :002B21
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000E65
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :001E54
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000E41
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :002F38
Links to Exploration step
ISTEX:E78B943017DC4445EA9ED4F232C3C26C3C38391DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study</title>
<author><name sortKey="Espay, Alberto J" sort="Espay, Alberto J" uniqKey="Espay A" first="Alberto J." last="Espay">Alberto J. Espay</name>
</author>
<author><name sortKey="Beaton, Dorcas E" sort="Beaton, Dorcas E" uniqKey="Beaton D" first="Dorcas E." last="Beaton">Dorcas E. Beaton</name>
</author>
<author><name sortKey="Morgante, Francesca" sort="Morgante, Francesca" uniqKey="Morgante F" first="Francesca" last="Morgante">Francesca Morgante</name>
</author>
<author><name sortKey="Gunraj, Carolyn A" sort="Gunraj, Carolyn A" uniqKey="Gunraj C" first="Carolyn A." last="Gunraj">Carolyn A. Gunraj</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</author>
<author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E78B943017DC4445EA9ED4F232C3C26C3C38391D</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/mds.22480</idno>
<idno type="url">https://api.istex.fr/document/E78B943017DC4445EA9ED4F232C3C26C3C38391D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001106</idno>
<idno type="wicri:Area/Istex/Curation">001106</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E62</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Espay A:impairments:of:speed</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19230031</idno>
<idno type="wicri:Area/PubMed/Corpus">001E06</idno>
<idno type="wicri:Area/PubMed/Curation">001E06</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001D66</idno>
<idno type="wicri:Area/Ncbi/Merge">002571</idno>
<idno type="wicri:Area/Ncbi/Curation">002571</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002571</idno>
<idno type="wicri:Area/Main/Merge">002B21</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:09-0257358</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E65</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001E54</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000E41</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Espay A:impairments:of:speed</idno>
<idno type="wicri:Area/Main/Merge">002F38</idno>
<idno type="wicri:Area/Main/Curation">002260</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study</title>
<author><name sortKey="Espay, Alberto J" sort="Espay, Alberto J" uniqKey="Espay A" first="Alberto J." last="Espay">Alberto J. Espay</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beaton, Dorcas E" sort="Beaton, Dorcas E" uniqKey="Beaton D" first="Dorcas E." last="Beaton">Dorcas E. Beaton</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Mobility Program Clinical Research Unit, Department of Medicine, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Morgante, Francesca" sort="Morgante, Francesca" uniqKey="Morgante F" first="Francesca" last="Morgante">Francesca Morgante</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Dipartimento di Neuroscienze, Scienze Psichiatriche ed Anestesiologiche, Università di Messina, Messina</wicri:regionArea>
<wicri:noRegion>Messina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gunraj, Carolyn A" sort="Gunraj, Carolyn A" uniqKey="Gunraj C" first="Carolyn A." last="Gunraj">Carolyn A. Gunraj</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009-05-15">2009-05-15</date>
<biblScope unit="vol">24</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="1001">1001</biblScope>
<biblScope unit="page" to="1008">1008</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">E78B943017DC4445EA9ED4F232C3C26C3C38391D</idno>
<idno type="DOI">10.1002/mds.22480</idno>
<idno type="ArticleID">MDS22480</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Amplitude</term>
<term>Biomechanical Phenomena</term>
<term>Cross-Sectional Studies</term>
<term>Disability Evaluation</term>
<term>Evaluation scale</term>
<term>Female</term>
<term>Humans</term>
<term>Hypokinesia (etiology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Pilot Projects</term>
<term>Psychomotor Performance (physiology)</term>
<term>Reproducibility of Results</term>
<term>Severity of Illness Index</term>
<term>Speed</term>
<term>Task Performance and Analysis</term>
<term>bradykinesia</term>
<term>unified Parkinson's disease rating scale</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hypokinesia</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Psychomotor Performance</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Biomechanical Phenomena</term>
<term>Cross-Sectional Studies</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pilot Projects</term>
<term>Reproducibility of Results</term>
<term>Severity of Illness Index</term>
<term>Task Performance and Analysis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Amplitude</term>
<term>Echelle d'évaluation</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Vitesse déplacement</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Bradykinesia, characterized by slowness and decreased amplitude of movement, is often considered the most important deficit in Parkinson's disease (PD). The current clinical rating of bradykinesia in PD, based on the motor subscale of the Unified Parkinson's disease Rating Scale (UPDRS‐III), does not individually weigh the impairments in speed and amplitude of rapid alternating movements. We sought to categorize movement in PD to determine whether speed and amplitude have different relationships to current measures of motor impairment and disability. Categories of speed and amplitude (normal, slow/low, and very‐slow/very‐low) were ascertained using an electromagnetic tracking device. Amplitude was disproportionally more affected than speed in the “off” state. UPDRS‐III and the Schwab & England disability scale were worst in patients with very impaired amplitude and best in patients with normal amplitude. A similarly graded relationship was not found for categories of speed impairment. The examiner clinical global impression of change mirrored “off” state amplitude but not speed categories. Levodopa, however, normalized speed to a greater extent than amplitude. Our observations suggest that amplitude and speed impairments may be associated with different functional aspects in PD and deserve separate clinical assessment. © 2009 Movement Disorder Society</div>
</front>
</TEI>
<double idat="0885-3185:2009:Espay A:impairments:of:speed"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Impairments of Speed and Amplitude of Movement in Parkinson's Disease: A Pilot Study</title>
<author><name sortKey="Espay, Alberto J" sort="Espay, Alberto J" uniqKey="Espay A" first="Alberto J." last="Espay">Alberto J. Espay</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati</s1>
<s2>Cincinnati, Ohio</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beaton, Dorcas E" sort="Beaton, Dorcas E" uniqKey="Beaton D" first="Dorcas E." last="Beaton">Dorcas E. Beaton</name>
<affiliation wicri:level="4"><inist:fA14 i1="03"><s1>Mobility Program Clinical Research Unit, Department of Medicine, University of Toronto</s1>
<s2>Ontario</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Morgante, Francesca" sort="Morgante, Francesca" uniqKey="Morgante F" first="Francesca" last="Morgante">Francesca Morgante</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Dipartimento di Neuroscienze, Scienze Psichiatriche ed Anestesiologiche, Universitd di Messina</s1>
<s2>Messina</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Messina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gunraj, Carolyn A" sort="Gunraj, Carolyn A" uniqKey="Gunraj C" first="Carolyn A." last="Gunraj">Carolyn A. Gunraj</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0257358</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0257358 INIST</idno>
<idno type="RBID">Pascal:09-0257358</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E65</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001E54</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000E41</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Espay A:impairments:of:speed</idno>
<idno type="wicri:Area/Main/Merge">002F38</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Impairments of Speed and Amplitude of Movement in Parkinson's Disease: A Pilot Study</title>
<author><name sortKey="Espay, Alberto J" sort="Espay, Alberto J" uniqKey="Espay A" first="Alberto J." last="Espay">Alberto J. Espay</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati</s1>
<s2>Cincinnati, Ohio</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beaton, Dorcas E" sort="Beaton, Dorcas E" uniqKey="Beaton D" first="Dorcas E." last="Beaton">Dorcas E. Beaton</name>
<affiliation wicri:level="4"><inist:fA14 i1="03"><s1>Mobility Program Clinical Research Unit, Department of Medicine, University of Toronto</s1>
<s2>Ontario</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Morgante, Francesca" sort="Morgante, Francesca" uniqKey="Morgante F" first="Francesca" last="Morgante">Francesca Morgante</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Dipartimento di Neuroscienze, Scienze Psichiatriche ed Anestesiologiche, Universitd di Messina</s1>
<s2>Messina</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Messina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gunraj, Carolyn A" sort="Gunraj, Carolyn A" uniqKey="Gunraj C" first="Carolyn A." last="Gunraj">Carolyn A. Gunraj</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amplitude</term>
<term>Evaluation scale</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Speed</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Vitesse déplacement</term>
<term>Amplitude</term>
<term>Echelle d'évaluation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Bradykinesia, characterized by slowness and decreased amplitude of movement, is often considered the most important deficit in Parkinson's disease (PD). The current clinical rating of bradykinesia in PD, based on the motor subscale of the Unified Parkinson's disease Rating Scale (UPDRS-III), does not individually weigh the impairments in speed and amplitude of rapid alternating movements. We sought to categorize movement in PD to determine whether speed and amplitude have different relationships to current measures of motor impairment and disability. Categories of speed and amplitude (normal, slow/low, and very-slow/very-low) were ascertained using an electromagnetic tracking device. Amplitude was disproportionally more affected than speed in the "off" state. UPDRS-III and the Schwab & England disability scale were worst in patients with very impaired amplitude and best in patients with normal amplitude. A similarly graded relationship was not found for categories of speed impairment. The examiner clinical global impression of change mirrored "off" state amplitude but not speed categories. Levodopa, however, normalized speed to a greater extent than amplitude. Our observations suggest that amplitude and speed impairments may be associated with different functional aspects in PD and deserve separate clinical assessment.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study</title>
<author><name sortKey="Espay, Alberto J" sort="Espay, Alberto J" uniqKey="Espay A" first="Alberto J." last="Espay">Alberto J. Espay</name>
</author>
<author><name sortKey="Beaton, Dorcas E" sort="Beaton, Dorcas E" uniqKey="Beaton D" first="Dorcas E." last="Beaton">Dorcas E. Beaton</name>
</author>
<author><name sortKey="Morgante, Francesca" sort="Morgante, Francesca" uniqKey="Morgante F" first="Francesca" last="Morgante">Francesca Morgante</name>
</author>
<author><name sortKey="Gunraj, Carolyn A" sort="Gunraj, Carolyn A" uniqKey="Gunraj C" first="Carolyn A." last="Gunraj">Carolyn A. Gunraj</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</author>
<author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E78B943017DC4445EA9ED4F232C3C26C3C38391D</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/mds.22480</idno>
<idno type="url">https://api.istex.fr/document/E78B943017DC4445EA9ED4F232C3C26C3C38391D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001106</idno>
<idno type="wicri:Area/Istex/Curation">001106</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E62</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Espay A:impairments:of:speed</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19230031</idno>
<idno type="wicri:Area/PubMed/Corpus">001E06</idno>
<idno type="wicri:Area/PubMed/Curation">001E06</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001D66</idno>
<idno type="wicri:Area/Ncbi/Merge">002571</idno>
<idno type="wicri:Area/Ncbi/Curation">002571</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002571</idno>
<idno type="wicri:Area/Main/Merge">002B21</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study</title>
<author><name sortKey="Espay, Alberto J" sort="Espay, Alberto J" uniqKey="Espay A" first="Alberto J." last="Espay">Alberto J. Espay</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beaton, Dorcas E" sort="Beaton, Dorcas E" uniqKey="Beaton D" first="Dorcas E." last="Beaton">Dorcas E. Beaton</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Mobility Program Clinical Research Unit, Department of Medicine, University of Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Morgante, Francesca" sort="Morgante, Francesca" uniqKey="Morgante F" first="Francesca" last="Morgante">Francesca Morgante</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Dipartimento di Neuroscienze, Scienze Psichiatriche ed Anestesiologiche, Università di Messina, Messina</wicri:regionArea>
<wicri:noRegion>Messina</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gunraj, Carolyn A" sort="Gunraj, Carolyn A" uniqKey="Gunraj C" first="Carolyn A." last="Gunraj">Carolyn A. Gunraj</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009-05-15">2009-05-15</date>
<biblScope unit="vol">24</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="1001">1001</biblScope>
<biblScope unit="page" to="1008">1008</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">E78B943017DC4445EA9ED4F232C3C26C3C38391D</idno>
<idno type="DOI">10.1002/mds.22480</idno>
<idno type="ArticleID">MDS22480</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Biomechanical Phenomena</term>
<term>Cross-Sectional Studies</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>Hypokinesia (etiology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson's disease</term>
<term>Pilot Projects</term>
<term>Psychomotor Performance (physiology)</term>
<term>Reproducibility of Results</term>
<term>Severity of Illness Index</term>
<term>Task Performance and Analysis</term>
<term>bradykinesia</term>
<term>unified Parkinson's disease rating scale</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hypokinesia</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Psychomotor Performance</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Biomechanical Phenomena</term>
<term>Cross-Sectional Studies</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pilot Projects</term>
<term>Reproducibility of Results</term>
<term>Severity of Illness Index</term>
<term>Task Performance and Analysis</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Bradykinesia, characterized by slowness and decreased amplitude of movement, is often considered the most important deficit in Parkinson's disease (PD). The current clinical rating of bradykinesia in PD, based on the motor subscale of the Unified Parkinson's disease Rating Scale (UPDRS‐III), does not individually weigh the impairments in speed and amplitude of rapid alternating movements. We sought to categorize movement in PD to determine whether speed and amplitude have different relationships to current measures of motor impairment and disability. Categories of speed and amplitude (normal, slow/low, and very‐slow/very‐low) were ascertained using an electromagnetic tracking device. Amplitude was disproportionally more affected than speed in the “off” state. UPDRS‐III and the Schwab & England disability scale were worst in patients with very impaired amplitude and best in patients with normal amplitude. A similarly graded relationship was not found for categories of speed impairment. The examiner clinical global impression of change mirrored “off” state amplitude but not speed categories. Levodopa, however, normalized speed to a greater extent than amplitude. Our observations suggest that amplitude and speed impairments may be associated with different functional aspects in PD and deserve separate clinical assessment. © 2009 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002260 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002260 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:E78B943017DC4445EA9ED4F232C3C26C3C38391D |texte= Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |